Patient with Papillary Thyroid Cancer
Patient had a right vocal cord paralysis unfortunately with her first surgery.
Now with left central neck recurrence on FNA, surgical consultant is concerned that attempt at repeat surgery risks a injury to the left recurrent laryngeal nerve, and that this would lead to a tracheostomy and permanent voice issues.
RFA is a alternative to this scenario , We are planning to use hydrodissection technique to inject cold D5W behind the mass in the TE groove to protect the nerve and then do radiofrequency ablation of this metastatic node with 0.5 cm active tip.
We have made this move to outpatient in office treatment after our successful publication confirming our results recently shared at the Endocrine Society National meeting
https://www.abstractsonline.com/pp8/#!/7897/presentation/6961
We are the most experienced clinic offering this technique in the United States
Being able to offer this nonsurgical cutting age minimally invasive technique in a painless setting in our office makes it more convenient and much more affordable
Other centers are advertising locally for this technique but lack the experience and frequently are in surgical offices and might funnell patient to surgery rather than this very effective technique which helps patients preserve their thyroid function with much lower complications
We are Currently evaluating Patient's For treatment to be scheduled in June"
Pioneering cutting edge non-surgical alternatives for the treatment of benign thyroid nodules
We are the most experienced group doing RFA procedures and we have a track record of exquisite safety with no complications after more than 30 procedures. We are in the process of publishing our data.
RFA of
large thyroid nodule was carried out under local anesthetic
Total ablation time: 2 minutes
No complications noted.
One of my first cases in 2019.
RFA of large
compressive thyroid nodule
More than 30 nodules treated a year , patients are happy avoiding surgery and recovering in less than half an hour after the procedure.
RFA of Medullary Thyroid Cancer
First ever RFA of Medullary thyroid cancer in USA using the STARmed system.
Thyroid Clinic RFA Thyroid Patient Testimonial
RFA Procedure
RFA can change your life, so take the next step and learn more about this amazing procedure.
RFA Experience
Listen to the amazing experiences patients have had with the advance procedure of RFA.
Dr Shahzad Ahmed
Dr. Shahzad Ahmad has performed more RFA procedures than any other endocrinologist in the United States — more than 1,200 cases to date, with a complication rate of just 0.2%.
He performed the first successful North American RFA procedures on a parathyroid tumor and the first North American RFA of a medullary thyroid cancer recurrence, and was the first physician in the United States to perform RFA on a toxic (hyperfunctioning) thyroid nodule.
Dr. Ahmad completed his residency in Internal Medicine at Mount Sinai School of Medicine in Englewood, New Jersey, followed by an Endocrinology fellowship at Harbor-UCLA. His clinical focus is the diagnosis and medical treatment of thyroid dysfunction, nodules, and cancer. He has also served as an Assistant Professor at the University of San Francisco School of Medicine.
He is ECNU certified — a credential awarded to endocrinologists with demonstrated expertise in thyroid ultrasound and procedures — and is a Certified Interventional Endocrinologist (CIE). Dr. Ahmad currently serves as President-Elect of the North American Society of Interventional Endocrinologists (NASOIE).
A recognized leader in advancing percutaneous thyroid ablation in North America, Dr. Ahmad has published more than 10 original peer-reviewed papers on RFA. He was among the first to bring the technique to the United States, training extensively on tissue models, with his earliest cases observed by the STARmed team from Korea under the guidance of RFA pioneer Dr. Jung Hwan Baek of Seoul, South Korea